<DOC>
	<DOCNO>NCT01345656</DOCNO>
	<brief_summary>A placebo ( Part A ) placebo active comparator control ( Part B ) , double-blind randomize study ass safety tolerability new drug ( BAY94-8862 ) give orally</brief_summary>
	<brief_title>BAY94-8862 Dose Finding Trial Subjects With Chronic Heart Failure Mild ( Part A ) Moderate ( Part B ) Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Men age 18 year old postmenopausal woman age 55 year old woman age 18 year old without childbearing potential base surgical treatment bilateral tubal ligation , bilateral ovarectomy , hysterectomy Clinical diagnosis CHF ( chronic heart failure ) , either ischemic nonischemic , NYHA ( New York Heart Association ) class II III , treat evidencedbased therapy CHF , e.g . betablockers ACE ( angiotensinconverting enzyme ) inhibitor ARB ( angiotensin receptor blocker ) well diuretic , unless contraindicate tolerate Known kidney damage &gt; /= 3 month , define structural functional abnormality kidney , Part A : 60 mL/min/1.73 m2 &lt; /= eGFR ( estimate Glomerular Filtration Rate ) &lt; 90 mL/min/1.73 m2 ( MDRD , Modification Diet Renal Disease ) screen visit Part B : 30 mL/min/1.73 m2 &lt; /= eGFR &lt; = 60 mL/min/1.73 m2 ( MDRD ) screen visit Serum potassium &lt; /= 4.8 mmol/L screen visit Systolic blood pressure &gt; /= 90 mmHg without sign symptom hypotension screen visit Known hypersensitivity study drug ( active substance excipients ) spironolactone respective excipients ( Part B ) Subjects anuria , acute renal failure , Addison 's disease Acute coronary syndrome unstable coronary artery disease within 30 day prior randomization Valvular heart disease require surgical intervention course study History hospitalization hyperkalemia acute renal failure induce previous aldosterone antagonist treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Chronic Heart Failure</keyword>
</DOC>